WVEWave Life Sciences Ltd.
$3.47-50% 1Y
$3.47
$3.4752 weeks$21.31
The financials
Wave Life Sciences Ltd. by the numbers
Wave Life Sciences Ltd. (WVE) reported revenue of $2.3M in Q2 2026 (quarter ended Jun 30, 2026), down 74% from the same quarter a year earlier. That came with net loss of $69M. For the full year FY2025, revenue was $43M (−61% year on year) and net income −$204M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $2.3M | $8.7M | −74% |
| Operating income | −$74M | −$53M | n/a |
| Net income | −$69M | −$50M | n/a |
| Diluted EPS | −$0.34 | −$0.31 | n/a |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q4 2024Total $70.1M (+23267%)
Category One Programs grew +594% year on year
Segment Latestquarter on quarteryear on year
- Category One Programs$70.1M$70.1Mquarter on quarter +23267%year on year +594%+23267%+594%